These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12081763)

  • 1. Prognostic significance of nuclear morphometry in renal cell carcinoma.
    Ozer E; Yörükoğlu K; Sagol O; Mungan U; Demirel D; Tüzel E; Kirkali Z
    BJU Int; 2002 Jul; 90(1):20-5. PubMed ID: 12081763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of nuclear morphometry in superficial bladder cancer.
    Ozer E; Yörükoğlu K; Mungan MU; Ozkal S; Demirel D; Sağol O; Kirkali Z
    Anal Quant Cytol Histol; 2001 Aug; 23(4):251-6. PubMed ID: 11531139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between histological grade and nuclear morphometry for predicting the clinical outcome of localized renal cell carcinoma.
    Nativ O; Sabo E; Bejar J; Halachmi S; Moskovitz B; Miselevich I
    Br J Urol; 1996 Jul; 78(1):33-8. PubMed ID: 8795397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative activity, angiogenesis and nuclear morphometry in renal cell carcinoma.
    Kirkali Z; Yorukoglu K; Ozkara E; Kazimoglu H; Mungan U
    Int J Urol; 2001 Dec; 8(12):697-703. PubMed ID: 11851771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computerized nuclear morphometry and survival in renal cell carcinoma: comparison with other prognostic indicators.
    Delahunt B; Becker RL; Bethwaite PB; Ribas JL
    Pathology; 1994 Oct; 26(4):353-8. PubMed ID: 7892031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of morphometric nuclear image analysis using the Feulgen reaction in renal cell carcinoma.
    Lee JS; Jung JJ; Lee MC; Park CS; Juhng SW; Oh BR; Moon JD
    Anal Quant Cytol Histol; 2000 Feb; 22(1):31-6. PubMed ID: 10696458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unclassified renal cell carcinoma: a report of 56 cases.
    Lopez-Beltran A; Kirkali Z; Montironi R; Blanca A; Algaba F; Scarpelli M; Yorukoglu K; Hartmann A; Cheng L
    BJU Int; 2012 Sep; 110(6):786-93. PubMed ID: 22404824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinoma.
    Carducci MA; Piantadosi S; Pound CR; Epstein JI; Simons JW; Marshall FF; Partin AW
    Urology; 1999 Jan; 53(1):44-9. PubMed ID: 9886586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma.
    Eskelinen M; Lipponen P; Aitto-Oja L; Hall O; Syrjänen K
    Int J Cancer; 1993 Oct; 55(4):547-54. PubMed ID: 8406980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of sarcomatoid histology and volume-weighted mean nuclear volume in renal cell carcinoma.
    Kanamaru H; Sasaki M; Miwa Y; Akino H; Okada K
    BJU Int; 1999 Feb; 83(3):222-6. PubMed ID: 10233484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
    Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
    Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear quantitative grading by discriminant analysis of renal cell carcinoma samples. A patient survival evaluation.
    Artacho-Pérula E; Roldán-Villalobos R; Martínez-Cuevas JF; López-Rubio F
    J Pathol; 1994 Jun; 173(2):105-14. PubMed ID: 8089804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective nuclear morphometry as a prognostic factor of survival in renal cell carcinoma.
    Monge JM; Val-Bernal JF; Buelta L; García-Castrillo L; Asensio L
    Histol Histopathol; 1999 Jan; 14(1):119-23. PubMed ID: 9987656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma.
    Sika-Paotonu D; Bethwaite PB; McCredie MR; William Jordan T; Delahunt B
    Am J Surg Pathol; 2006 Sep; 30(9):1091-6. PubMed ID: 16931953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system.
    Montironi R; Santinelli A; Pomante R; Mazzucchelli R; Colanzi P; Filho AL; Scarpelli M
    Virchows Arch; 2000 Jul; 437(1):82-9. PubMed ID: 10963384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
    Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
    Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the secreted form of clusterin protein in renal cell carcinoma as a predictor of disease extension.
    Kurahashi T; Muramaki M; Yamanaka K; Hara I; Miyake H
    BJU Int; 2005 Oct; 96(6):895-9. PubMed ID: 16153225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear morphometry as an important prognostic factor in stage I renal cell carcinoma.
    Tosi P; Luzi P; Baak JP; Miracco C; Santopietro R; Vindigni C; Mattei FM; Acconcia A; Massai MR
    Cancer; 1986 Dec; 58(11):2512-8. PubMed ID: 3768843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.